Creatine kinase is a marker of metabolic syndrome in qatari women with and without polycystic ovarian syndrome

8Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Objective: To correlate features of metabolic syndrome with creatine kinase (CK) in women with and without polycystic ovary syndrome (PCOS). Design: Comparative cross-sectional analysis. Methods: Demographic and metabolic data from Qatari women aged 18–40 years from the Qatar Biobank (97 diagnosed with PCOS, 563 controls). The primary outcome was the association between plasma CK and features of metabolic syndrome. Results: CK increased when the waist circumference was >80 cm (p < 0.015) and when associated with 2 or more features of the metabolic syndrome (p < 0.01). CK correlated with BMI (p < 0.003) but not with waist/hip ratio. Overall, CK did not differ between PCOS and controls, rising equally in both as body mass index (BMI) increased. C reactive protein (CRP) was higher in obese PCOS (P < 0.05) compared to controls, but did not correlate with CK (p > 0.05). Conclusion: CK was associated with an increase in BMI, waist circumference >80 cm and 2 or more features of the metabolic syndrome, in accord with the central role of type II skeletal muscle fibers in energy metabolism and obesity. CK was, however, independent of the PCOS phenotype.

Cite

CITATION STYLE

APA

Al-Hail, N., Butler, A. E., Dargham, S. R., Seif, A. A., & Atkin, S. L. (2019). Creatine kinase is a marker of metabolic syndrome in qatari women with and without polycystic ovarian syndrome. Frontiers in Endocrinology, 10(SEP). https://doi.org/10.3389/fendo.2019.00659

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free